Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MAIA Biotechnology, Inc. (MAIA) just unveiled an announcement.
Starting April 1, 2024, Jeffrey Himmelreich’s employment agreement will see his base salary raised to $250,000, with his target annual bonus climbing to 25% of his base salary, reflecting a substantial increase in his compensation package.
Find detailed analytics on MAIA stock on TipRanks’ Stock Analysis page.